Amgen Inc. (NASDAQ:AMGN) is one of the best next generation dividend aristocrat stocks. The company has built a solid track ...

Amgen Inc. (NASDAQ:AMGN) is one of the 15 best stocks to invest in for an 18 year old. Amgen Inc. (NASDAQ:AMGN) highlighted ...

Mass., and Rep. Jan Schakowsky, D-Ill., on Tuesday reportedly questioned five pharmaceutical companies about paying little ...

What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet when ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this ...

Drugmaker Amgen Inc. is asking a federal appeals court to overturn a judge’s dismissal of its lawsuit seeking to prevent ...

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...